• Leucine Tech
• 29 Oct, 2019

The number of drug GMP warning letters continues to increase from 20 in FY2015 to 44 in FY2016 to 61 in FY2017. The number of warning letters for FY2018 and FY2019 is expected to maintain this trend. Focus on data integrity and data governance related guidelines will continue to increase and companies must adopt measures to ensure compliance.
Read more...